$AGEN AGENUS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGENUS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in AGENUS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
AGENUS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AFEYAN NOUBAR | Director | 0 | 0 | Apr 03 2007 | |||
| ARMEN GARO H | Chairman and CEO | 600,011 | 2,394,044 | May 07 2021 | |||
| ARMEN GARO H | Chairman & CEO | 916,776 | 3,657,936 | Jan 03 2013 | |||
| ARMEN GARO H | Chairman & CEO | 511,533 | 2,041,017 | May 02 2012 | |||
| ARMEN GARO H | Chairman & CEO | 657,004 | 2,621,446 | Oct 29 2012 | |||
| ARMEN GARO H | Chairman & CEO | 1,309,567 | 5,225,172 | Feb 17 2015 | |||
| ARMEN GARO H | Chairman and CEO | 11,414,274 | 45,542,953 | Oct 21 2004 | |||
| ARMEN GARO H | Chairman & CEO | 1,161,690 | 4,635,143 | Jun 29 2009 | |||
| ARMEN GARO H | Chairman & CEO | 508,087 | 2,027,267 | Apr 03 2012 | |||
| ARMEN GARO H | Chairman and CEO | 181,610 | 724,624 | Mar 13 2007 | |||
| ARMEN GARO H | Chairman & CEO | 1,120,099 | 4,469,195 | May 01 2009 | |||
| ARMEN GARO H | Chairman & CEO | 1,365,068 | 5,446,621 | Aug 05 2009 | |||
| ARMEN GARO H | Chairman & CEO | 1,396,677 | 5,572,741 | Nov 03 2009 | |||
| ATLEE FRANK V III | Director | 0 | 0 | Apr 04 2007 | |||
| ATLEE FRANK V III | Director | 0 | 0 | Jan 17 2006 | |||
| Ballantyne Charles Evan | CFO | 14,648 | 58,446 | Jun 16 2016 | |||
| Baysal Ozer | Chief Commercial Officer | 62,502 | 249,383 | Jun 22 2018 | |||
| Baysal Ozer | Chief Business Officer | 0 | 0 | Jun 17 2013 | |||
| Buell Jennifer | President & COO | 116,494 | 464,811 | Apr 05 2021 | |||
| CHADAREVIAN GAMIL DE | Director | 0 | 0 | May 28 2004 | |||
| CHADAREVIAN GAMIL DE | Director | 88,610 | 353,554 | Mar 02 2006 | |||
| Chicz Roman | SVP, Research and Development | 0 | 0 | Jan 08 2007 | |||
| CLARK JEFF D | Chief Financial Officer | 0 | 0 | Feb 20 2004 | |||
| CLARK PAUL N | Director | 0 | 0 | Apr 05 2021 | |||
| Cortis Christian | Chief Strategy Officer | 0 | 0 | Jul 25 2019 | |||
| Corvese Brian | Director | 92,085 | 367,419 | Jun 21 2021 | |||
| Corvese Brian | Director | 0 | 0 | Jun 18 2012 | |||
| Corvese Brian | Director | 0 | 0 | Jun 17 2013 | |||
| Corvese Brian | Director | 0 | 0 | Apr 29 2014 | |||
| Cuillerot Jean-Marie | Chief Medical Officer | 0 | 0 | Jan 30 2017 | |||
| DECHAENE TOM | Director | 0 | 0 | Jan 06 2016 | |||
| DECHAENE TOM | Director | 0 | 0 | Jul 02 2014 | |||
| DECHAENE TOM | Director | 0 | 0 | Oct 03 2014 | |||
| DECHAENE TOM | Director | 0 | 0 | Jan 18 2005 | |||
| DECHAENE TOM | Director | 0 | 0 | Oct 02 2013 | |||
| DECHAENE TOM | Director | 0 | 0 | Apr 03 2012 | |||
| DECHAENE TOM | Director | 0 | 0 | Jun 18 2012 | |||
| DECHAENE TOM | Director | 0 | 0 | Jul 03 2012 | |||
| DECHAENE TOM | Director | 0 | 0 | Oct 03 2012 | |||
| DECHAENE TOM | Director | 0 | 0 | Jan 03 2013 | |||
| DECHAENE TOM | Director | 0 | 0 | Jan 06 2015 | |||
| Duncan Alex | Chief Technology Officer | 27,572 | 110,012 | Jul 25 2019 | |||
| GORDON NEAL | SrVP, Manufacturing Operations | 0 | 0 | Feb 20 2004 | |||
| GUPTA RENU | Sr. Vice President | 0 | 0 | Oct 21 2004 | |||
| GUPTA RENU | SVP, Development | 0 | 0 | Feb 28 2006 | |||
| HATSOPOULOS JOHN | Director | 0 | 0 | Jul 06 2011 | |||
| HATSOPOULOS JOHN | Director | 0 | 0 | Oct 05 2011 | |||
| HATSOPOULOS JOHN | Director | 55,000 | 219,450 | Apr 05 2011 | |||
| HATSOPOULOS JOHN | Director | 0 | 0 | Jun 15 2010 | |||
| HATSOPOULOS JOHN | Director | 0 | 0 | May 17 2010 | |||
| HATSOPOULOS JOHN | Director | 0 | 0 | Jan 05 2011 | |||
| HATSOPOULOS JOHN | Director | 0 | 0 | Jun 20 2011 | |||
| HERNDON RUSSELL | Pres, Commercial Operations | 0 | 0 | Dec 13 2004 | |||
| Hirsch Susan B | Director | 8,729 | 34,829 | Apr 05 2021 | |||
| INCYTE CORP | 10% Owner | 17,114,888 | 68,288,403 | Jun 18 2020 | |||
| Jeynes-Ellis Allison M | Director | 49,323 | 196,799 | Dec 21 2020 | |||
| JORDAN WADIH | Director | 0 | 0 | Jan 06 2021 | |||
| JORDAN WADIH | Director | 0 | 0 | Jul 02 2014 | |||
| JORDAN WADIH | Director | 0 | 0 | Oct 03 2014 | |||
| JORDAN WADIH | Director | 0 | 0 | Jan 05 2010 | |||
| JORDAN WADIH | Director | 0 | 0 | Jan 05 2012 | |||
| JORDAN WADIH | Director | 0 | 0 | Apr 03 2012 | |||
| JORDAN WADIH | Director | 0 | 0 | Jun 18 2012 | |||
| JORDAN WADIH | Director | 0 | 0 | Jul 03 2012 | |||
| JORDAN WADIH | Director | 0 | 0 | Oct 03 2012 | |||
| JORDAN WADIH | Director | 0 | 0 | Jan 03 2013 | |||
| JORDAN WADIH | Director | 0 | 0 | Jan 06 2015 | |||
| Kearns Evan | VP and General Counsel | 0 | 0 | Dec 21 2020 | |||
| KESSEL MARK | Director | 0 | 0 | Oct 05 2006 | |||
| KLASKIN CHRISTINE M | PFO & PAO | 88,611 | 353,558 | Apr 05 2021 | |||
| KLASKIN CHRISTINE M | VP, Finance | 20,363 | 81,248 | Mar 16 2012 | |||
| KLASKIN CHRISTINE M | VP Finance | 23,273 | 92,859 | Oct 29 2012 | |||
| KLASKIN CHRISTINE M | VP Finance | 20,780 | 82,912 | Jun 21 2012 | |||
| KLASKIN CHRISTINE M | VP, Finance | 23,690 | 94,523 | Feb 17 2015 | |||
| Krauss Adam | Chief Legal Officer | 0 | 0 | Dec 21 2020 | |||
| Leicher Bruce | VP, General Counsel | 0 | 0 | Sep 19 2006 | |||
| Levitsky Hyam | Director | 0 | 0 | Jun 11 2007 | |||
| Levitsky Hyam | Director | 15,376 | 61,350 | Jun 15 2009 | |||
| Levitsky Hyam | Director | 0 | 0 | Jul 06 2011 | |||
| Malik Shahzad | Director | 1,587,302 | 6,333,335 | Jun 17 2016 | |||
| Malik Shahzad | Director | 0 | 0 | Apr 29 2014 | |||
| MARGARET EISEN | Director | 20,000 | 79,800 | Jun 06 2008 | |||
| QVT Associates GP LLC | 10% Owner | 6,915,630 | 27,593,364 | Jan 13 2015 | |||
| ROTHWELL TIMOTHY G | Director | 0 | 0 | May 17 2010 | |||
| ROTHWELL TIMOTHY G | Director | 0 | 0 | Jun 15 2010 | |||
| ROTHWELL TIMOTHY G | Director | 7,389 | 29,482 | Oct 05 2011 | |||
| Sharp Shalini | Director | 104,270 | 416,037 | Jun 22 2018 | |||
| Sharp Shalini | Director | 81,599 | 325,580 | Apr 29 2014 | |||
| Sharp Shalini | CFO | 69,252 | 276,315 | Mar 16 2012 | |||
| Sharp Shalini | CFO | 69,877 | 278,809 | Apr 30 2012 | |||
| Sharp Shalini | Director | 0 | 0 | Jun 18 2012 | |||
| Sharp Shalini | Director | 76,265 | 304,297 | Jun 21 2012 | |||
| Sharp Shalini | Director | 76,890 | 306,791 | Jul 30 2012 | |||
| Sharp Shalini | Director | 80,637 | 321,742 | Sep 14 2012 | |||
| Sharp Shalini | Director | 81,262 | 324,235 | Oct 29 2012 | |||
| Sharp Shalini | Director | 80,974 | 323,086 | Nov 01 2012 | |||
| SRIVASTAVA PRAMOD | Director | 1,610 | 6,424 | Feb 13 2007 | |||
| Stein Robert Benjamin | President R&D | 20,776 | 82,896 | Jun 16 2016 | |||
| Thornton Peter | Director | 5,000 | 19,950 | Jun 11 2007 | |||
| Thornton Peter | Director | 0 | 0 | Jun 06 2008 | |||
| Valentine Karen | Chief Legal Officer and GC | 109,879 | 438,417 | Jun 22 2018 | |||
| Valentine Karen | VP, General Counsel | 0 | 0 | Jun 17 2013 | |||
| Wentworth Kerry | VP Reg Affairs & Clinical Ops | 5,885 | 23,481 | Jan 08 2008 | |||
| Wentworth Kerry | VP, Clinical, Reg & Qual | 57,410 | 229,066 | Feb 28 2014 | |||
| Wentworth Kerry | VP, Clin, Reg & Quality | 140,537 | 560,743 | Jan 28 2010 | |||
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 30,283 | 120,829 | Jun 21 2012 | |||
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 45,065 | 179,809 | Apr 30 2012 | |||
| Wentworth Kerry | VP, Clin, Reg & Quality | 37,410 | 149,266 | Jan 29 2013 | |||
| Wentworth Kerry | VP Clinical, Reg & Quality | 36,021 | 143,724 | Sep 14 2012 | |||
| Wentworth Kerry | VP Clin, Reg & Quality | 36,716 | 146,497 | Oct 29 2012 | |||
| Wentworth Kerry | VP, Clinicial, Reg, & Quality | 0 | 0 | Jun 17 2013 | |||
| WIINBERG ULF | Director | 82,210 | 328,018 | Jan 06 2021 | |||
| Wood Alastair JJ | Director | 0 | 0 | Jun 22 2006 | |||
| Wright Timothy | Director | 53,876 | 214,965 | Jan 06 2021 | |||
| Wright Timothy | Director | 0 | 0 | Jul 02 2014 |